The planned spinoff will allow for greater investment focus in the areas of “highest strategic priority” and help execute Medtronic’s leadership strategy in attractive medtech markets, the company said in an October.
Discussions with Carlyle Group, a private equity firm, have slowed, the report said. The devicemaker was looking to sell the businesses for about $10 billion.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
